CMXC Stock
Price Chart
CMXC Financial and Trading Overview
| stock price | 0.43 |
| Previous Close | 1.0E-6 |
| Open | 1.0E-6 |
| Bid | 0 x 0 |
| Ask | 0 x 0 |
| Day's Range | 1.0E-6 - 1.0E-6 |
| 52 Week Range | 1.0E-6 - 0.12 |
| Volume | 6.1K |
| Avg. Volume | 0 |
| Market Cap | 62 |
| Beta (5Y Monthly) | -3.235211 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CMXC Valuation Measures
| Enterprise Value | 747.52K |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.01094826 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 132 |
| Enterprise Value/EBITDA | -1.377 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | -3.235211 |
| 52-Week Change | -64.39% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.12 |
| 52 Week Low | 1.0E-6 |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.04 |
CMXC Share Statistics
| Avg. Volume (3 month) | 0 |
| Avg. Daily Volume (10-Days) | 0 |
| Shares Outstanding | 62.92M |
| Float | 37.85M |
| Short Ratio | N/A |
| % Held by Insiders | 39.85% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | May 31, 2022 |
| Most Recent Quarter (mrq) | November 30, 2022 |
| Next Fiscal Year End | May 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -9602.66% |
| Gross Margin | 45.84% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -703.70% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 5.66K |
| Revenue Per Share (ttm) | 0 |
| Quarterly Revenue Growth (yoy) | 16.69% |
| Gross Profit (ttm) | N/A |
| EBITDA | -542824 |
| Net Income Avi to Common (ttm) | -579548 |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 17.81K |
| Total Cash Per Share (mrq) | 0 |
| Total Debt (mrq) | 765.27K |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.011 |
| Book Value Per Share (mrq) | -0.035 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -325563 |
| Levered Free Cash Flow (ttm) | -224196 |
Profile of
| Country | United States |
| State | NV |
| City | Carson City |
| Address | 123 West Nye Lane |
| ZIP | 89706 |
| Phone | 844 238 2692 |
| Website | https://cellmedx.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is headquartered in Carson City, Nevada.
Q&A For Stock
What is a current CMXC stock price?
CMXC stock price today per share is 0.43 .
How to purchase stock?
You can buy CMXC shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ?
The stock symbol or ticker of is CMXC.
Which industry does the company belong to?
The industry is Medical Devices.
How many shares does have in circulation?
The max supply of shares is 0.
What is Price to Earnings Ratio (PE Ratio)?
PE Ratio is 0.00000000 now.
What was earnings per share over the trailing 12 months (TTM)?
EPS is 0 over the trailing 12 months.
Which sector does the company belong to?
The sector is Healthcare.